December 2nd 2025, 10:00pm
By Dave Seaney
I explain how the words caregiver and incurable shaped my wife’s cancer journey and why I believe more hopeful language better reflects our experience.
December 2nd 2025, 9:00pm
By Cindy Mrotek
Cindy and Katie share how finding a friend who understood the caregiving journey made the experience less isolating and helped them navigate loss and hope.
December 2nd 2025, 8:00pm
By Ryan Scott
Although most patients with localized kidney cancer have high cancer-specific survival, surveys show a gap between doctor and patient perceptions of cure.
December 2nd 2025, 6:00pm
By Alex Biese
CURE recently sat down with an expert to discuss crucial information for patients with gastrointestinal stromal tumors, or GISTs.
December 2nd 2025, 5:00pm
By Bonnie Annis
A stamp on my Christmas cards stirred deep memories and reminded me that small actions can make a meaningful impact in the fight against breast cancer.
December 2nd 2025, 4:00pm
Among young patients, clinical trial results have shown that Pedmark is associated with a reduction in chemotherapy-induced ear damage.
December 2nd 2025, 2:00pm
By Dr. Ajay Gupta
An expert explained what patients newly diagnosed with gastrointestinal stromal tumors need to know.
December 1st 2025, 10:00pm
By Karen Cohn
Feeling like others have it worse can dismiss the real challenges of follicular lymphoma and leave patients without the support they need.
December 1st 2025, 9:00pm
By Dr. Adam J. Schoenfeld
Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.
December 1st 2025, 8:00pm
By Erin Jordan-Perin
Only 5% to 10% of breast cancers are caused by inherited gene mutations like BRCA1 or BRCA2. I do not carry one. But my family history was enough.
December 1st 2025, 6:00pm
By Chester Freeman
I love flowers, and I especially love the Japanese tradition of ikebana. In Japanese culture, ikebana is the art of flower arrangement.
December 1st 2025, 4:57pm
By Spencer Feldman
Optimism, treatment momentum and communication gaps drive late systemic therapy, increasing hospitalization and intensive care use for patients with cancer.
December 1st 2025, 4:00pm
The FDA approved Armlupeg as a biosimilar to Neulasta to reduce infection risk in people receiving chemotherapy and those exposed to radiation.
December 1st 2025, 2:00pm
By Kimberly Alexander
November 30th 2025, 7:00pm
Meta: Stage 1 essential thrombocythemia is a chronic blood disorder with high platelets, manageable through monitoring, medication, lifestyle and care.
Why I Think the Term ‘Non-Curable’ Should be Changed to ‘Can Be’
How Friendship Helped Two Cholangiocarcinoma Caregivers Find Hope
Cured or Consumed? How Kidney Cancer Patients Experience Survival
GIST: Early Warning Signs and First Steps